ANNOUNCEMENT
New Member – Dr. Shigeki Ishikawa
April 3, 2024

Credits: WPI-Bio2Q
Introducing new member of Bio2Q
We are delighted to welcome Dr. Shigeki Ishikawa as our Principal Investigator at Q core of Bio2Q.
The greeting from Dr. Ishikawa is as follows:
“I started working as a Bio2Q Advisor at the end of November 2023, and in April 2024 I started working as a P.I. of Bio2Q project professor of the Q-core team.
I worked for IBM’s Research & Development until 2020, as an executive management of new business creation utilizing leading edge new technologies, such as AI, Quantum computing, formulating new strategies, promoting new technology, and providing educational support. Combination of new IT and domains such medicine, healthcare , is quite an exciting new area for human lives, then I focused on this for 10 years there.
Since 2021, I have been appointed as a specially appointed professor at the AI Consortium at Keio University, Faculty of Science and Engineering, where I have worked with students to launch AI education and provide guidance on basic education and projects that utilize AI.
At Bio2Q, I will mainly contribute to the development of strategy & roadmap of Quantum Computing & AI in Bio-1・Bio-2 for accelerating biology research. Those technologies will make it possible to improve research quality and speed further more. At first, we are focusing on generative AI for Bio-1 ・Bio2 research.
I am very excited about this new challenge. I am looking forward to working with you to make Bio2Q much more exciting.”
More Bio2Q News
[Publication] Brain-wide mapping of immune receptors uncovers a neuromodulatory ...
This work reveals that immune molecules actively shape brain circuits, challenging the idea they only appear in disease and shedding light o...
[Publication] Emerging sensitivity to talking mouth in infants with low and elev...
This study shows that infants at higher risk for autism spectrum disorders pay less attention to talking mouths, a key cue for social develo...
[Publication] Microbiota-dependent modulation of intestinal anti-inflammatory CD...
This review, co-authored by a Bio2Q researcher, shows how gut microbes actively shape immunity and highlights new therapies like engineered ...
[Publication] Human Hepatocyte Organoids That Function Like the Real Thing
Bio2Q affiliated, Keio University, researchers have developed self-renewing human hepatocyte organoids that perform key liver functions and ...